Hyperthermia products find distribution in South Korea
Salt Lake City, UT - (April 14, 2015) - Pyrexar Medical, the makers of PYREXAR HT Hyperthermia-based cancer treatment systems, announced today that it had received orders for the first two units, of a multi-unit contract, for the BSD-2000 Deep Regional Hyperthermia Systems from the distribution group HanBeam Technology.
Hyperthermia is a type of cancer treatment in which tumors are exposed to elevated body temperatures, between 104˚ and 113°F. Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to healthy tissues. Hyperthermia treatment has achieved a high clinical response when combined with radiotherapy in the treatment of cancer. “We are very pleased to have HanBeam Technology as a distribution partner,” says Mark Falkowski, CEO. “HanBeam has a solid reputation as a radiation solutions provider in the Korean peninsula.”
ABOUT HANBEAM TECHNOLOGY:
HanBeam Technology Co., Ltd is known for installing the world’s first single-room proton therapy system and the world’s first View Ray system combining MRI, radiation cancer treatment, Intraoperative Radiation Therapy (IORT) and the BSD-2000 Hyperthermia system capable of thermal cancer treatment. The company is supplying and managing cutting-edge cancer treatment equipment to South Korea and beyond. Building on medical equipment expertise and experiences, the company has spearheaded the adoption of advanced medical equipment to the country.
For the past decade, the company contributed to the use of enhanced robotic radiosurgery by providing Cyberknife to major Korean cancer treatment centers and university hospitals, improving patient care in the hospital environment
Multi-center clinical trials in the US, Europe, and Asia over the past 30 years document dramatic improvement in survival rates when PYREXAR HT is combined with radiotherapy in the treatment of chest wall recurrences after breast cancer, locally advanced cervical cancer, high-risk soft tissue sarcoma, melanoma, and other malignancies.
Pyrexar Medical is based in Salt Lake City, UT, USA. For more information, please visit our web page at www.pyrexar.com
Pyrexar Medical Media Contact:
Drew Wilkens
VP of Digital Marketing
844-797-3927